1.Genetic analysis of Echinococcus granulosus strain in Liaoning Province, China
Xiaoli WANG ; Fei LI ; Jinhui LI ; Jing LIU ; Yacai LI ; Yang BAI ; Chunli AN
Chinese Journal of Zoonoses 2017;33(2):110-114
To analyze the genotype of Echinococcus granulosus found in Liaoning Province,hydatid cyst was taken from the patient's liver,DNA of cyst was isolated and mitochondrial cox1 gene was sequenced substantially.Sequence results was analyzed by Blast and compared with similar strains in GenBank.Results showed that molecular analysis confirmed the echinococcosis by identical sequence of our strain with E.granulosus (AF297617) G1 genotype,with 0.1% difference.And the sequence of our strain was consistent with 25 other strains in different countries.In conclusion,genotyping of mitochondrial gene coxl is a very useful tool for diagnosis of echinococcosis.We first reported a strain of E.granulosus in Liaoning Province,which provide novel molecular epidemiological data of this zoonosis.
2.Chimeric antigen receptor T cell immunotherapy for sustained remission of double expression diffuse large B-cell lymphoma after the recurrence of autologous hematopoietic stem cell transplantation: report of one case and review of literature
Yuqi LIN ; Xiangli CHEN ; Yuzhu ZANG ; Lei ZHANG ; Wenhui ZHANG ; Kai SUN ; Yacai WANG
Journal of Leukemia & Lymphoma 2020;29(5):288-290
Objective:To investigate the therapeutic efficacy of chimeric antigen receptor T cell (CAR-T) for treatment of relapsed patients with double expression lymphoma after autologous hematopoietic stem cell transplantation (auto-HSCT).Methods:The treatment process of one patient with double expression diffuse large B-cell lymphoma who received CAR-T immunotherapy after the recurrence of auto-HSCT in Henan Provincial People's Hospital in August, 2017 was retrospectively analyzed, and the related literature was reviewed.Results:A 50-year-old female double expression diffuse large B-cell lymphoma patient received the standard treatment regimen, and then had auto-HSCT based on the BEAM preconditioning regimen. The patient relapsed after 5 months, and finally got sustained remission after chemotherapy regimen containing cladribine for 2 courses of treatment combined with CAR-T therapy. CD20 +-CAR-T cells were detected in this patient for 8 mouths sustainably. Conclusion:For relapsed patients with non-Hodgkin lymphoma after auto-HSCT, reduction remission of the treatment regimen containing cladribine followed by CAR-T sequential regimen may be a better treatment option.